CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Aug 24, 2026

Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
59.6%
-15.4% vs 52w high · -13.7% 1mo

Price (last ~year)

CVS Health reported Q2 2026 revenue of $106.10 billion, a 7.1% year-over-year increase, while beating earnings estimates for the fourth consecutive quarter. The company generated $5.65 billion in free cash flow against $76.31 billion in total debt, though the stock has declined 13.7% over the past month to an RSI of 21. Institutional activity remains active, with several firms establishing new positions in the company during the second quarter.

Valuation

Market cap
$118.97B
P/E
24.54
PEG
0.25
P/B
1.493
P/S
0.288
EV/EBITDA
13.52
Beta
0.596
Analyst target
$116.08

Quality & returns

Gross margin
13.6%
Operating margin
3.9%
Profit margin
1.2%
ROE
6.2%
ROA
3.0%

Price movement

Last
$93.02
1-month
-13.7%
3-month
+1.7%
RSI (14)
21
vs SMA200
+9.8%
52-wk position
59.6% -15.4% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$106.10B$4.70B$3.00B$5.86B
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots